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Cancer is one of the leading causes of death every year. Advancement of nanotechnology in the
biomedical field could provide a solution by crafting an efficient drug delivery system consisting
of mesoporous silica nanoparticles that offer excellent target specificity, biocompatibility,
biodegradability, and reduce side effects on healthy tissues and retain the anti-cancer drugs for
more extended periods. Because researchers in the field are failing to scale and reproduce these
nanocarriers due to their cost and the long time it takes to perfect them, the goal of this project is
to optimize the synthesis of the nanoparticles to find the minimum conditions required that
would yield functional and efficient nanocarriers for drug delivery. Micro-emulsion methods will
be compared, varying parameters such as temperature, the concentration of surfactants and pH,
to observe how changing these variables affects the size, porosity, shape, and zeta potential of
the particles. Water-in-oil and oil-in-water micro-emulsions will be the two primary methods
used to synthesize silica nanoparticles. Dynamic Light Scattering (DLS) measurements will be
taken to compare size and zeta potential of nanoparticles synthesized under different conditions surfactants, co-surfactants, pH, type of micro-emulsion, and dialysis time, etc.-. A double-beam
spectrophotometer will be used to compare the fraction of light that reflects from the supernatant
extracted from a sample of centrifuged nanoparticles with grafted amine groups, to a reference
sample that was not centrifuged because it never had functionalized nanoparticles. The fraction
of light reflected is useful to calculate the sample absorbency, which is a value proportional to
the concentration of amine groups being measured. If successful, the project would represent a
turning point in the biomedical field because the production of silica nanocarriers could be taken
to the larger, industrial scale and potentially reduce the number of deaths to cancer.

